According to TG Therapeutics's latest financial reports the company's current earnings (TTM) are $25.67 M. an increase over its 2022 earnings that were of -$0.19 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $25.67 M | -113.65% |
2022 | -$0.19 B | -45.06% |
2021 | -$0.35 B | 25.42% |
2020 | -$0.28 B | 62.93% |
2019 | -$0.17 B | -3.34% |
2018 | -$0.18 B | 46.05% |
2017 | -$0.12 B | 48.38% |
2016 | -$80.01 M | 29.09% |
2015 | -$61.98 M | 12.99% |
2014 | -$54.86 M | 180.92% |
2013 | -$19.53 M | |
2009 | -$1.78 M | -59.85% |
2008 | -$4.42 M | |
2006 | -$10.01 M | -48.34% |
2005 | -$19.36 M | 215.12% |
2004 | -$6.15 M | 29.1% |
2003 | -$4.76 M | 159.59% |
2002 | -$1.84 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Alkermes ALKS | $0.44 B | 1,631.32% | ๐ฎ๐ช Ireland |
Dr. Reddy's RDY | $0.85 B | 3,225.77% | ๐ฎ๐ณ India |